Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Bolla

Showing results (111-120 of 158) with videos related to

Pageof 16
Sort By:
Scientific Reports|January 12, 2017
Corrigendum: A unique peptide deformylase platform to rationally design and challenge novel active compoundsSonia Fieulaine, Rodolphe Alves de Sousa, Laure Maigre, et al.
Mlife|July 2, 2025
The polyamino-isoprenyl enhancer NV716 enables the antibacterial activity of two families of multi-target inhibitors against the ESKAPEE bacterium <i>Enterobacter cloacae</i>Emma Forest, Jordan Lehoux, Alexandre Guy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2007
Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911Theodorus H Van der Kwast, Michel Bolla, Hein Van Poppel, et al.
Journal of Molecular Biology|October 4, 2016
MOMP from Campylobacter jejuni Is a Trimer of 18-Stranded β-Barrel Monomers with a Ca<sup>2+</sup> Ion Bound at the Constriction ZoneLuana G M Ferrara, Gregor D Wallat, Lucile Moynié, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 21, 2007
Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology GroupPhilip Poortmans, Alberto Bossi, Katia Vandeputte, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2004
Late toxicity following conventional radiotherapy for prostate cancer: analysis of the EORTC trial 22863Fatma Ataman, Alfredo Zurlo, Xavier Artignan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2008
Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case reviewOscar Matzinger, Philip Poortmans, Jean-Yves Giraud, et al.
The New England Journal of Medicine|May 7, 2004
Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancerJacques Bernier, Christian Domenge, Mahmut Ozsahin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 21, 2007
Outcome and prognostic factors in breast sarcoma: a multicenter study from the rare cancer networkGuilhem Bousquet, Cyril Confavreux, Nicolas Magné, et al.
BJU International|March 30, 2010
Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric OncologyJean-Pierre Droz, Lodovico Balducci, Michel Bolla, et al.
Pageof 16

Showing results (111-120 of 158) with videos related to

Sort By:
Pageof 16
Scientific Reports|January 12, 2017
Corrigendum: A unique peptide deformylase platform to rationally design and challenge novel active compoundsSonia Fieulaine, Rodolphe Alves de Sousa, Laure Maigre, et al.
Mlife|July 2, 2025
The polyamino-isoprenyl enhancer NV716 enables the antibacterial activity of two families of multi-target inhibitors against the ESKAPEE bacterium <i>Enterobacter cloacae</i>Emma Forest, Jordan Lehoux, Alexandre Guy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2007
Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911Theodorus H Van der Kwast, Michel Bolla, Hein Van Poppel, et al.
Journal of Molecular Biology|October 4, 2016
MOMP from Campylobacter jejuni Is a Trimer of 18-Stranded β-Barrel Monomers with a Ca<sup>2+</sup> Ion Bound at the Constriction ZoneLuana G M Ferrara, Gregor D Wallat, Lucile Moynié, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 21, 2007
Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology GroupPhilip Poortmans, Alberto Bossi, Katia Vandeputte, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2004
Late toxicity following conventional radiotherapy for prostate cancer: analysis of the EORTC trial 22863Fatma Ataman, Alfredo Zurlo, Xavier Artignan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2008
Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case reviewOscar Matzinger, Philip Poortmans, Jean-Yves Giraud, et al.
The New England Journal of Medicine|May 7, 2004
Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancerJacques Bernier, Christian Domenge, Mahmut Ozsahin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 21, 2007
Outcome and prognostic factors in breast sarcoma: a multicenter study from the rare cancer networkGuilhem Bousquet, Cyril Confavreux, Nicolas Magné, et al.
BJU International|March 30, 2010
Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric OncologyJean-Pierre Droz, Lodovico Balducci, Michel Bolla, et al.
Pageof 16